PerkinElmer in Agreement to Acquire Caliper Life Sciences

PerkinElmer, (Waltham, Massachusetts), has entered into a definitive agreement to acquire Caliper Life Sciences, (Hopkinton, Massachusetts), with the goal of uniting key technologies for imaging, detection, and sample preparation solutions, services, and expertise.

The acquisition will allow the company to provide help with translational research by combining imaging, informatics, biomarker detection, assays, and services. Additionally, the move will allow access to complementary solutions ranging from basic research to preclinical studies, diagnostics, and environmental engineering.

Other expected benefits of the agreement include more efficient experimental workflows through an expanded sample preparation portfolio across life science, diagnostics, and environmental markets via microfluidics and DNA purification, and resources that include assay development, automation integration, multivendor asset management, custom research and profiling therapeutics screening, and environmental toxicology.

The purchase of Caliper Life Sciences is expected to close in the fourth quarter, subject to customary closing conditions.